BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Pompili S, Vitale F, Martellucci S, Marampon F, Mattei V, Biordi L, Sherris D, Festuccia C. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. Cancers (Basel) 2019;11:E1604. [PMID: 31640252 DOI: 10.3390/cancers11101604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Rodríguez-camacho A, Flores-vázquez JG, Moscardini-martelli J, Torres-ríos JA, Olmos-guzmán A, Ortiz-arce CS, Cid-sánchez DR, Pérez SR, Macías-gonzález MDS, Hernández-sánchez LC, Heredia-gutiérrez JC, Contreras-palafox GA, Suárez-campos JDJE, Celis-lópez MÁ, Gutiérrez-aceves GA, Moreno-jiménez S. Glioblastoma Treatment: State-of-the-Art and Future Perspectives. IJMS 2022;23:7207. [DOI: 10.3390/ijms23137207] [Reference Citation Analysis]
2 Gravina GL, Colapietro A, Mancini A, Rossetti A, Martellucci S, Ventura L, Di Franco M, Marampon F, Mattei V, Biordi LA, Otterlei M, Festuccia C. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. Cancers (Basel) 2022;14:289. [PMID: 35053455 DOI: 10.3390/cancers14020289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brai A, Riva V, Clementi L, Falsitta L, Zamperini C, Sinigiani V, Festuccia C, Sabetta S, Aiello D, Roselli C, Garbelli A, Trivisani CI, Maccari L, Bugli F, Sanguinetti M, Calandro P, Chiariello M, Quaranta P, Botta L, Angelucci A, Maga G, Botta M. Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models. Cancers (Basel) 2021;13:5569. [PMID: 34771731 DOI: 10.3390/cancers13215569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Colapietro A, Rossetti A, Mancini A, Martellucci S, Ocone G, Pulcini F, Biordi L, Cristiano L, Mattei V, Delle Monache S, Marampon F, Gravina GL, Festuccia C. Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma. Pharmaceuticals (Basel) 2021;14:1082. [PMID: 34832864 DOI: 10.3390/ph14111082] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Bolcaen J, Nair S, Driver CHS, Boshomane TMG, Ebenhan T, Vandevoorde C. Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals (Basel) 2021;14:626. [PMID: 34209513 DOI: 10.3390/ph14070626] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Dorrell MI, Kast-Woelbern HR, Botts RT, Bravo SA, Tremblay JR, Giles S, Wada JF, Alexander M, Garcia E, Villegas G, Booth CB, Purington KJ, Everett HM, Siles EN, Wheelock M, Silva JA, Fortin BM, Lowey CA, Hale AL, Kurz TL, Rusing JC, Goral DM, Thompson P, Johnson AM, Elson DJ, Tadros R, Gillette CE, Coopwood C, Rausch AL, Snowbarger JM. A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis. PLoS One 2021;16:e0252233. [PMID: 34077449 DOI: 10.1371/journal.pone.0252233] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gómez-Oliva R, Domínguez-García S, Carrascal L, Abalos-Martínez J, Pardillo-Díaz R, Verástegui C, Castro C, Nunez-Abades P, Geribaldi-Doldán N. Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments. Front Oncol 2020;10:614295. [PMID: 33585240 DOI: 10.3389/fonc.2020.614295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
8 Colapietro A, Mancini A, Vitale F, Martellucci S, Angelucci A, Llorens S, Mattei V, Gravina GL, Alonso GL, Festuccia C. Crocetin Extracted from Saffron Shows Antitumor Effects in Models of Human Glioblastoma. Int J Mol Sci 2020;21:E423. [PMID: 31936544 DOI: 10.3390/ijms21020423] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]